Ortivity
Overview
Ortivity is a German-based HealthTech startup specializing in outpatient orthopedic care. Founded in 2022 by Dr. med. Reinhard Wichels and Apheon, a pan-European private equity investor, Ortivity has rapidly expanded its operations with over 100 sites across Germany. The startup focuses on providing a full spectrum of orthopedic services, from diagnostics and surgeries to aftercare, using a physician-led partnership model. Recently, Ortivity secured a significant funding round of approximately €200 million, led by existing investor Apheon and new partner Unigestion, to bolster its expansion and innovation efforts.
Recent Developments
-
August 2025: Ortivity received a fresh capital injection of around €200 million, led by Apheon with participation from Swiss private equity firm Unigestion. This funding aims to accelerate the expansion of Ortivity’s physician-led orthopedic care model across Germany, marking a significant milestone in the company's growth trajectory. Dr. med. Michael Thorwarth was appointed as Co-CEO to spearhead this new phase.
-
July 2025: Ortivity made headlines with its majority acquisition of NARCONOVA, an anesthesiology practice group in North Rhine-Westphalia. This strategic move allows Ortivity to integrate outpatient surgical services, enhancing its footprint in the German healthcare market.
-
April 2024: The company continued its expansion strategy by acquiring Beta Klinik Service, aiming to strengthen its service offerings in non-invasive orthopedic treatments.
-
January 2024: Ortivity, backed by Apheon, acquired a significant stake in the anesthesiology group NARCONOVA, which will bolster its operational capabilities and cement its position as a leading outpatient care provider.
These strategic developments demonstrate Ortivity's aggressive growth strategy, leveraging acquisitions and partnerships to expand its market reach and enhance service offerings.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2022 |
| Headquarters | Munich, Germany |
| Founders | Dr. med. Reinhard Wichels, Apheon |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Apheon, Unigestion |
| Industry | Clinics/Outpatient Services |
| Number of Employees | Approximately 1,500 |
Early History
Ortivity was born out of a collaboration between Dr. med. Reinhard Wichels and Apheon to create an innovative platform for outpatient orthopedic care. Launched in 2022, the company swiftly gained prominence by securing substantial investment from Apheon. The initial focus was on building a network of orthopedic practices across Germany that emphasized high-quality, patient-centered care. The company's commitment to integrating advanced medical technologies and a physician-led model quickly distinguished it in the burgeoning HealthTech landscape.
Company Profile and Achievements
Ortivity has established itself as Germany's leading outpatient platform for orthopedic care within a remarkably short time frame. The startup operates over 100 locations across three major regions: North Rhine-Westphalia, Bavaria, and Baden-Württemberg. Key milestones include:
- Rapid Expansion: From inception, Ortivity has successfully expanded its network to over 100 sites within three years, positioning itself as a market leader.
- Unique Partnership Model: It operates on a collaborative ownership model where physicians and investors share ownership, ensuring a strong alignment of interests focused on patient care.
- Innovative Care Model: Ortivity integrates diagnostics, surgery, and aftercare into a seamless patient experience, setting new standards for orthopedic care.
- Strategic Acquisitions: These have played a critical role in Ortivity’s growth, including the acquisition of NARCONOVA, a leading anesthesiology group.
Current Operations and Market Position
Currently, Ortivity stands as a dominant player in the outpatient orthopedic market in Germany. The company's model combines clinical expertise with cutting-edge technology, creating an efficient system that optimizes every stage of patient interaction, from scheduling to follow-up care. This has allowed Ortivity to maintain a robust market share, characterized by its commitment to high-quality care and operational excellence. Strategic partnerships and consistent investments have positioned Ortivity as a forward-thinking leader in the healthcare sector.
Ortivity Owner
Ortivity is primarily owned by Apheon, with Unigestion holding a significant minority stake following the latest investment round. This ownership structure highlights the collaborative nature of its financial and operational strategies, aligning investor interests with clinical goals to ensure sustainable growth and innovation.
Apheon Portfolio Companies
Apheon, the principal investor in Ortivity, manages a diverse range of companies across Europe, focusing on resilient sectors like healthcare. Ortivity is a key component of Apheon's portfolio, exemplifying the company's strategy to invest in transformative healthcare platforms that combine innovation with clinical excellence.
Conclusion
Ortivity has quickly ascended as a leading force in the German outpatient orthopedic market due to its innovative, integrated care model and strategic collaboration with physicians and investors. The company's growth trajectory suggests a promising future driven by expansion into new regional clusters and the enhancement of its care model, supported by strong financial backing from Apheon and Unigestion. As Ortivity continues to evolve, it sets a benchmark in the industry for quality patient care and operational efficiency, paving the way for future innovations in outpatient services.